These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30692446)

  • 1. [A Case of Borderline Resectable Pancreatic Head Cancer Treated by Curative Resection after Chemotherapy].
    Nakayasu Y; Shiozawa S; Usui T; Kuhara K; Kono T; Shimojima Y; Tsuchiya A; Miyauchi T; Asaka S; Yamaguchi K; Yokomizo H; Shimakawa T; Naritaka Y
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2306-2308. PubMed ID: 30692446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer.
    Ishikawa H; Kouki T; Oda R; Midorikawa R; Kojima S; Kinoe H; Kishimoto Y; Okabe M; Hosokawa Y; Okazaki T; Tayama K; Kosuga K; Ogou E; Akiba J; Yano H
    Gan To Kagaku Ryoho; 2021 Mar; 48(3):388-390. PubMed ID: 33790164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Borderline Resectable Pancreatic Cancer Responding to Preoperative GEM plus Nab-PTX Combination Chemotherapy].
    Fujimoto T; Ueno T; Sakamoto K; Matsukuma S; Matsui H; Shindo Y; Tokumitsu Y; Kanekiyo S; Iida M; Tokuhisa Y; Suzuki N; Takeda S; Yoshino S; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1978-1981. PubMed ID: 28133195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resectable Pancreatic Cancer Successfully Treated with Neoadjuvant Chemotherapy Regimen Change to Modified FOLFIRINOX-A Case Report].
    Terao H; Maruyama T; Aono T; Suzuki S; Kaneko K; Sato T; Okada T; Muto I; Hasegawa M; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1569-1571. PubMed ID: 38303344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Curative Resection of Pancreatic Head Cancer with Liver Metastasis after GEM plus Nab-PTX Therapy].
    Yotsumoto H; Yamamoto N; Kamiya M; Inoue H; Murakawa M; Aoyama T; Numata M; Hayashi T; Yamada T; Ohshima T; Shiozawa M; Rino Y; Masuda M; Morinaga S
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):169-171. PubMed ID: 30765677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?
    Kobayashi K; Ono Y; Sato S; Kato T; Oba A; Sato T; Ito H; Inoue Y; Takamatsu M; Saiura A; Takahashi Y
    Surgery; 2023 May; 173(5):1220-1228. PubMed ID: 36424197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report.
    Masui T; Kubota T; Aoki K; Nakanishi Y; Miyamoto T; Nagata J; Morino K; Fukugaki A; Takamura M; Sugimoto S; Onuma H; Tokuka A
    World J Surg Oncol; 2013 Aug; 11(1):195. PubMed ID: 23945441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic Cancer with Liver Metastasis Treated with Radical Surgery after Chemotherapy].
    Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Inatome J; Naito A; Murakami K; Kagawa Y; Takeno A; Egawa C; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1975-1977. PubMed ID: 28133194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical Resection of a Primarily Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy Using Gemcitabine, TS-1, and Nafamostat Mesilate; Report of a Case.
    Fujiwara Y; Shiba H; Uwagawa T; Futagawa Y; Misawa T; Yanaga K
    Int Surg; 2015 Feb; 100(2):287-91. PubMed ID: 25692432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Conversion Surgery for a Patient with Initially Unresectable Pancreatic Cancer with a Pathological Complete Response to S-1 Chemotherapy].
    Kamei K; Matsumoto I; Makutani Y; Kawaguchi K; Matsumoto M; Murase T; Satoi S; Nakai T; Kamata K; Imai H; Chikugo T; Takeyama Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1191-1193. PubMed ID: 29394577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
    Wang G; Zhou D
    Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
    Liu C; Lu Y; Luo G; Cheng H; Guo M; Liu Z; Xu J; Long J; Liu L; Fu D; Ni Q; Li M; Yu X
    Oncotarget; 2016 May; 7(20):29177-86. PubMed ID: 27081079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Synchronous Double Cancer including Borderline Resectable Pancreatic Body Cancer and Breast Carcinoma with Osseous/Cartilaginous Differentiation Treated with Neoadjuvant Chemotherapy and Radical Resection].
    Nakanishi K; Goto W; Ishihara A; Tauchi J; Kashiwagi S; Amano R; Kubo S; Ohira M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2005-2007. PubMed ID: 35045475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer.
    Jang JY; Kang MJ; Heo JS; Choi SH; Choi DW; Park SJ; Han SS; Yoon DS; Yu HC; Kang KJ; Kim SG; Kim SW
    Ann Surg; 2014 Apr; 259(4):656-64. PubMed ID: 24368638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Resected Pancreatic Adenosquamous Carcinoma with Early Hepatic Metastatic Recurrence].
    Ototake H; Sato H; Muto M; Nakagawa K; Masuda K; Ueno T; Goto H; Satoh A; Asonuma S; Kimura O; Hiramoto K; Okata H; Doi K; Miyazaki S; Shimosegawa T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1780-1782. PubMed ID: 36732997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous double primary malignancies of the pancreatic body and extrahepatic bile duct treated with pancreatoduodenectomy and splenic artery resection following neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel: a case report.
    Murokawa T; Okabayashi T; Sui K; Tabuchi M; Iwata J
    Surg Case Rep; 2022 Feb; 8(1):29. PubMed ID: 35171354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case Report of R0 Resection after Chemotherapy for Locally Advanced Pancreatic Head Cancer with Ureter Invasion].
    Eto R; Kataoka M; Yanagisawa S; Nishimura M; Kobayashi S; Okaniwa A; Watanabe Y; Senda T; Hayama A; Oka Y; Machida T; Saeda Y; Tsuchiya S; Kaiho T
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):712-714. PubMed ID: 32389993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.
    Gostimir M; Bennett S; Moyana T; Sekhon H; Martel G
    BMC Cancer; 2016 Oct; 16(1):786. PubMed ID: 27724927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.